Health and Fitness Health and Fitness
Wed, November 26, 2008
[ Wed, Nov 26th 2008 ] - Market Wire
Wyeth and Progenics Announce Positive Outcome of .. cutaneous RELISTOR for Opioid-Induced Constipatio
[ Wed, Nov 26th 2008 ] - Market Wire
Tarceva (erlotinib) Endorsed by the U.K. s Nati .. nd Clinical Excellence for Use in Patients with A
Tue, November 25, 2008
[ Tue, Nov 25th 2008 ] - Market Wire
BioScrip to Present at Piper Jaffray Health Care Conference
[ Tue, Nov 25th 2008 ] - Market Wire
St. Jude Medical To Present at Piper Jaffray 20th Annual Unplugged Health Care Conference
[ Tue, Nov 25th 2008 ] - Market Wire
ZymoGenetics Announces Filing of Registration Statement
[ Tue, Nov 25th 2008 ] - Market Wire
SurModics Announces New Board Director
[ Tue, Nov 25th 2008 ] - Market Wire
KCI s LifeCell Granted CE Mark for its Strattice Reconstructive Tissue Matrix
[ Tue, Nov 25th 2008 ] - Market Wire
Teva Announces Agreement on Generic Pulmicort Respules Patent Challenge
[ Tue, Nov 25th 2008 ] - Market Wire
Illumina to Present at the Piper Jaffray Health Care Conference
[ Tue, Nov 25th 2008 ] - Market Wire
RxElite, Inc.: RxElite, Inc. and Minrad International, Inc. Terminate Distributor Agreement
[ Tue, Nov 25th 2008 ] - Market Wire
Allion Healthcare to Present at Piper Jaffray Healthcare Conference
[ Tue, Nov 25th 2008 ] - Market Wire
Webcast Alert: Interview with Jay Higham, CEO, IntegraMed America
[ Tue, Nov 25th 2008 ] - Market Wire
William Blair & Company Initiates Coverage of Genoptix, Inc. With Market Perform Rating
[ Tue, Nov 25th 2008 ] - Market Wire
HST Global Quarterly Update
[ Tue, Nov 25th 2008 ] - Market Wire
Proxy Organizer Responds to Most Recent Improper Actions by Artes Medical
[ Tue, Nov 25th 2008 ] - Market Wire
ACADIA Pharmaceuticals to Present at The 20th Ann .. affray Health Care Conference on December 3, 2008
[ Tue, Nov 25th 2008 ] - Market Wire
Dynavax Announces Listing Transfer to The Nasdaq Capital Market from The Nasdaq Global Market
[ Tue, Nov 25th 2008 ] - Market Wire
AVANIR to Present at the Piper Jaffray 20th Annual Health Care Conference
[ Tue, Nov 25th 2008 ] - Market Wire
Health Net Names Chief Medical Officer
[ Tue, Nov 25th 2008 ] - Market Wire
Aspect Medical Systems Announces Departure of Chief Financial Officer
[ Tue, Nov 25th 2008 ] - Market Wire
Abraxis BioScience Announces Agreement to Re-Acqu .. ABRAXANE; Company Highlights Plans to Initiate Ni
[ Tue, Nov 25th 2008 ] - Market Wire
Optimer Pharmaceuticals to Present at the 20th Annual Piper Jaffray Health Care Conference
[ Tue, Nov 25th 2008 ] - Market Wire
Protalix BioTherapeutics to Present at the Piper Jaffray 20th Annual Health Care Conference
[ Tue, Nov 25th 2008 ] - Market Wire
Italian Cancer Center, Ospedali Riuniti, Chooses .. raOp Medical s Mobetron for Advanced Cancer Care
[ Tue, Nov 25th 2008 ] - Market Wire
CONMED Corporation: CONMED Corporation to Present .. 20th Annual Piper Jaffray Health Care Conference
[ Tue, Nov 25th 2008 ] - Market Wire
Enrollment in Provectus Phase 2 Melanoma Clinical Trial Reaches Halfway Point
[ Tue, Nov 25th 2008 ] - Market Wire
ARIAD to Present at the Piper Jaffray 20th Annual Healthcare Conference
[ Tue, Nov 25th 2008 ] - Market Wire
Acorda Therapeutics to Present at the Piper Jaffray 20th Annual Healthcare Conference
[ Tue, Nov 25th 2008 ] - Market Wire
Cytori Strengthens European Union Sales, Training and Service Operations
[ Tue, Nov 25th 2008 ] - Market Wire
Inspire Announces Webcast of Presentation at Piper Jaffray Conference

Inspire Announces Webcast of Presentation at Piper Jaffray Conference


Published on 2008-11-25 05:57:48 - Market Wire
  Print publication without navigation


DURHAM, N.C.--([ BUSINESS WIRE ])--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Christy L. Shaffer, Ph.D., President and CEO, will present at the Piper Jaffray 20th Annual Health Care Conference Tuesday, December 2, 2008 at 9:30 am ET in New York City.

Also in conjunction with the conference, Benjamin R. Yerxa, Ph.D., Executive Vice President and Chief, Research and Development, will participate on a cystic fibrosis panel Wednesday, December 3, 2008 at 10:00 am ET.

The webcast of Dr. Shaffer's presentation will be available on Inspire's web site at [ www.inspirepharm.com ]. An archived version of the webcast presentation will also be available through this link for a limited time following the conference.

About Inspire

Inspire is a biopharmaceutical company dedicated to discovering, developing and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases. Inspire is currently developing products for dry eye, cystic fibrosis and glaucoma. Inspire employs a U.S. sales force for the promotion of AzaSite® (azithromycin ophthalmic solution) 1% for bacterial conjunctivitis, Elestat® (epinastine HCl ophthalmic solution) 0.05% for allergic conjunctivitis and Restasis® (cyclosporine ophthalmic emulsion) 0.05% for dry eye. Elestat and Restasis are registered trademarks owned by Allergan, Inc. AzaSite is a registered trademark owned by InSite Vision Incorporated. For more information, visit [ www.inspirepharm.com ].

Contributing Sources